Chia Ling Wang
Director/Board Member bij UNITED BIOPHARMA INC
Profiel
Jia Ling Wang is currently a Director at Shanghai Baolong Automotive Corp., an Independent Director at United BioPharma, Inc., and a Professor at The Hong Kong University of Science & Technology.
Previously, Ms. Wang served as an Independent Non-Executive Director at Television Broadcasts Ltd.
from 2015 to 2021.
Ms. Wang received a graduate degree from Harvard University in 1977, an undergraduate degree from National Taiwan University in 1974, and a graduate degree from the University of Wisconsin-Milwaukee in 1976.
Actieve functies van Chia Ling Wang
| Bedrijven | Functie | Begin |
|---|---|---|
| UNITED BIOPHARMA INC | Director/Board Member | 30-09-2014 |
| SHANGHAI BAOLONG AUTOMOTIVE CORPORATION | Director/Board Member | 01-01-2014 |
| The Hong Kong University of Science & Technology | Corporate Officer/Principal | - |
Eerdere bekende functies van Chia Ling Wang
| Bedrijven | Functie | Einde |
|---|---|---|
| TELEVISION BROADCASTS LIMITED | Director/Board Member | 26-05-2021 |
Opleiding van Chia Ling Wang
| Harvard University | Graduate Degree |
| National Taiwan University | Undergraduate Degree |
| University of Wisconsin-Milwaukee | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| TELEVISION BROADCASTS LIMITED | Consumer Services |
| SHANGHAI BAOLONG AUTOMOTIVE CORPORATION | Producer Manufacturing |
| Bedrijven in privébezit | 1 |
|---|---|
United BioPharma, Inc.
 United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
